奧園美谷(000615.SZ):與暨南大學醫藥生物中心、暨源生物就醫美產學研合作達成初步意向
格隆匯 3 月 31日丨奧園美谷(000615.SZ)公佈,2021年3月31日,公司全資子公司廣州奧美產業研究有限公司與廣州暨南大學醫藥生物技術研究開發中心有限公司(“暨南大學醫藥生物中心”)、廣州市暨源生物科技有限公司(“暨源生物”)簽署《戰略合作協議》,就醫美產學研合作達成初步意向。
《戰略合作協議》的主要內容如下:
甲方:廣州奧美產業研究有限公司,乙方:廣州暨南大學醫藥生物技術研究開發中心有限公司,丙方:廣州市暨源生物科技有限公司。
基於乙方和丙方已通過基因工程及發酵技術成功研製開發了系列重組類人膠原蛋白原料,並完成產品中試,已經在部分市場高端醫美護膚產品中開展應用,在未來合作方向上,甲乙丙三方作為發起方共同推動重組類人膠原蛋白申請三類醫療器械,將其推向市場,完成產學研轉化,未來就產品市場推廣、產品市場運用、產品更新迭代研發將進行深入探討合作方式,甲方主要負責研發資金落實、聯繫專業資質申請機構同時負責產品市場推廣,乙方負責產品製劑開發及產品更新迭代研發,丙方負責原料的生產、協助註冊申報,產品線拓展運用等。
三方確立互為戰略合作伙伴關系,可以互相為對方推薦項目,並予以長期保持合作關係。
三方同意開展深入長期合作,並根據需要擴大和收縮合作範圍,增加和減少合作內容。
三方確定成立合作機構,負責提供合作資料,商定合作具體事宜,制定合作計劃,協調合作事項,落實合作事宜。
三方應儘可能支持對方發展、宣傳對方形象、維護對方聲譽、拓展合作領域。等等
該協議自三方簽字蓋章之日起生效,有效期為自2021年3月31日至2024年3月30日。如果甲、乙、丙三方對於彼此之間的合作感到滿意,經三方同意,則本協議將自動延續三年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.